How many insider trades does FilingIQ track for GRAL?

FilingIQ tracks 131 Form 4 insider transactions for GRAL (GRAIL, Inc.), covering filings from Jun 24, 2024 onwards. 17 of those are dated within the last 90 days.

Are GRAL insiders net buyers or net sellers?

Across the full Form 4 history for GRAL, 4 transactions (3%) were open-market purchases and 69 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GRAL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is GRAL in?

GRAIL, Inc. (GRAL) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $2.14B.

GRAL insider trading

NasdaqGS Healthcare

GRAIL, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

131

Last 90 days

Buys / sells

3% / 53%

Market cap

$2.14B

About GRAIL, Inc.

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Company website: grail.com

GRAL insider activity at a glance

FilingIQ tracks 131 insider transactions for GRAL in filings since Jun 24, 2024. The most recent transaction is dated Sep 21, 2026.

Across the full history, 4 open-market purchases and 69 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GRAL insider trades is 56.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live GRAL trades on FilingIQ Raw filings on SEC EDGAR

Latest GRAL Form 4 filings

Freidin Aaron Chief Financial Officer

S Sep 23, 2026

Ofman Joshua J. Chief Executive Officer

SM Sep 23, 2026

Ofman Joshua J. Chief Executive Officer

S Aug 31, 2026

Freidin Aaron Chief Financial Officer

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

13F funds holding GRAL

FARALLON CAPITAL MANAGEMENT, L.L.C.

$284.11M · 1.3% of AUM

BAKER BROS. ADVISORS LP

$275.03M · 1.4% of AUM

Frequently asked

How many insider trades does FilingIQ track for GRAL?: FilingIQ tracks 131 Form 4 insider transactions for GRAL (GRAIL, Inc.), covering filings from Jun 24, 2024 onwards. 17 of those are dated within the last 90 days.
Are GRAL insiders net buyers or net sellers?: Across the full Form 4 history for GRAL, 4 transactions (3%) were open-market purchases and 69 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GRAL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is GRAL in?: GRAIL, Inc. (GRAL) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $2.14B.

Methodology & sources

Every GRAL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.